Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics plus darifenacin for refractory detrusor overactivity in older women
ACTRN12613000285752Phase 4Recruiting
- Sponsor
- University of New South Wales
- Start
- Jun 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of darifenacin, amoxicillin + clavulanate, norfloxacin and nitrofurantoin in cystospasm, urge incontinence and bacterial cystitis (2 arms), sponsored by University of New South Wales. Primary endpoint: Relative change in urge incontinence. Started Jun 2014; status: recruiting.
02
Drugs
darifenacinamoxicillin + clavulanatenorfloxacinnitrofurantoin
03
Conditions
cystospasmurge incontinencebacterial cystitis
Beyond the preview
Go deeper on ACTRN12613000285752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000285752.